No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RLAY241220P20000
- 0.00
- 0.000.00%
15min DelayClose Dec 20 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest20.00Strike Price0.00Turnover0.00%IV-380.77%PremiumDec 20, 2024Expiry Date15.84Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.26Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
We Think Relay Therapeutics (NASDAQ:RLAY) Needs To Drive Business Growth Carefully
Relay Therapeutics Insider Sold Shares Worth $500,000, According to a Recent SEC Filing
JMP Securities Reiterates Market Outperform on Relay Therapeutics, Maintains $21 Price Target
Relay Therapeutics Analyst Ratings
TD Cowen Maintains Relay Therapeutics(RLAY.US) With Buy Rating
Jefferies Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $17